Search

everythinglearnresearchcommunity

for

Search:↓

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Method quickly measures finasteride concentration in capsules.

The FDA did not approve a testosterone drug because of safety concerns.

The document's conclusion about hair loss cannot be determined.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Tridax procumbens is a promising herb for developing safe, affordable plant-based medicines.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Low-dose oral minoxidil is more effective and convenient for treating male pattern baldness than topical minoxidil.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Topical treatments can help improve beard growth.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Liposomal adapalene improves delivery to hair follicles and reduces side effects for acne treatment.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Combination therapy for hair loss can improve results and reduce side effects.

Topical minoxidil increases hair density in androgenetic alopecia but has unclear clinical significance.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

A new treatment for hair loss shows promise with fewer side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

A medicinal cosmetic product for treating Androgenetic Alopecia was developed using plant-based substances, Saw palmetto and Japanese Sophora, with pumpkin seed oil and stabilizers like Carbopol, sodium alginate, xanthan gum, Tween-20 and cetyl alcohol.